Product Information

LEVORPHANOL 2 MG TABLET is a generic product labeled by Acertis Pharmaceuticals, LLC, priced at $16.3940 per EA under NDC 72989041710. Its NADAC has been published 53 times since Nov 19, 2025.

FDA first approved this application on Dec 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVORPHANOL 2 MG TABLET

Levorphanol Tartrate
$16.3940per EA
DEA Schedule CII

Strength

2 mg/1

NDC

72989041710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVORPHANOL TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211484

FDA Approved

12/13/2018

TE Code

AB

On Market Since

7/14/2025

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for LEVORPHANOL 2 MG TABLET has been published 53 times since Nov 19, 2025, and over the history we have for it it has risen 12.4%. The table below summarizes its recorded NADAC range and movement.

Current price$16.3940 per EA
All-time high$18.1292 (Nov 11, 2026)
All-time low$10.6456 (Feb 18, 2026)
52-week high$18.1292
52-week low$10.6456
Median price$10.6456
Average price$11.9665
Largest weekly change+70.3% (Oct 21, 2026)
Weeks tracked53
Tracking sinceNov 19, 2025

Price History

1W

-9.6%

1M

+54.0%

3M

+54.0%

6M

+54.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

+12.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVORPHANOL 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVORPHANOL 2 MG TABLET, manufactured by Acertis Pharmaceuticals, LLC, is $16.3940 per EA (NDC 72989041710), effective Nov 18, 2026.

How has the price of LEVORPHANOL 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVORPHANOL 2 MG TABLET has risen 12.4%. It has been tracked across 53 weekly CMS publications since Nov 19, 2025.

What are the highest and lowest recorded NADAC prices for LEVORPHANOL 2 MG TABLET?

Since Nov 19, 2025, the NADAC for LEVORPHANOL 2 MG TABLET has ranged from a low of $10.6456 (Feb 18, 2026) to a high of $18.1292 (Nov 11, 2026), with a median of $10.6456 per EA.

Are there cheaper alternatives to LEVORPHANOL 2 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVORPHANOL 2 MG TABLET, is $10.6456 per EA — about 35% below LEVORPHANOL 2 MG TABLET.

Who manufactures LEVORPHANOL 2 MG TABLET?

LEVORPHANOL 2 MG TABLET (NDC 72989041710) is labeled by Acertis Pharmaceuticals, LLC, and CMS classifies it as a generic product.